4
Changes in Ownership
Prime Medicine, Inc. Filed Acc 0001894562-25-000004
Options or other derivatives
- Chief Business Officer acquired 225,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Brudnick Richard Chief Business Officer | 2025-02-27 | Grant or award · Stock Option (right to buy) | +225,000 | 225,000 | D | ||
Loading xslF345X05/wk-form4_1741050750.xml…